Approaches for enhancing the informativeness and quality of clinical trials: Innovations and principles for implementing multicenter trials from the Trial Innovation Network

被引:3
|
作者
Lane, Karen [1 ]
Palm, Marisha E. E. [2 ,3 ]
Marion, Eve [4 ]
Kay, Marie T. T. [5 ]
Thompson, Dixie [5 ]
Stroud, Mary [6 ]
Boyle, Helen [4 ]
Hillery, Shannon [7 ]
Nanni, Angeline [7 ]
Hildreth, Meghan [1 ]
Nelson, Sarah [8 ]
Burr, Jeri S. S. [5 ]
Edwards, Terri [6 ]
Poole, Lori [4 ]
Waddy, Salina P. P. [9 ]
Dunsmore, Sarah E. E. [9 ]
Harris, Paul [10 ]
Wilkins, Consuelo [11 ]
Bernard, Gordon R. R. [6 ]
Dean, J. Michael [5 ]
Dwyer, Jamie [5 ]
Benjamin, Daniel K. K. [4 ]
Selker, Harry P. P. [3 ,12 ,13 ]
Hanley, Daniel F. F. [14 ]
Ford, Daniel E. E. [15 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA
[2] Tufts Med Ctr, Boston, MA USA
[3] Tufts Med Ctr, Inst Clin Res, Hlth Policy Studies, Boston, MA USA
[4] Duke Univ, Duke Clin Res Inst, Sch Med, Durham, NC USA
[5] Univ Utah, Sch Med, Salt Lake City, UT USA
[6] Vanderbilt Univ, Vanderbilt Inst Clin & Translat Res, Med Ctr, Nashville, TN USA
[7] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[8] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[9] Natl Ctr Adv Translat Sci, Div Clin Innovat, Bethesda, MD USA
[10] Vanderbilt Univ Sch Med, Nashville, TN USA
[11] Vanderbilt Univ, Dept Med, Med Ctr, Nashville, TN USA
[12] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA USA
[13] Tufts Med Ctr, Hlth Policy Studies, Boston, MA USA
[14] Johns Hopkins Univ, Sch Med, Acute Care Neurol, Baltimore, MD USA
[15] Johns Hopkins Univ, Inst Clin & Translat Res, Sch Med, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
Multicenter trials; informative trials; Trial Innovation Network; study planning; clinical trial budgets; clinical trial resources;
D O I
10.1017/cts.2023.560
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
One challenge for multisite clinical trials is ensuring that the conditions of an informative trial are incorporated into all aspects of trial planning and execution. The multicenter model can provide the potential for a more informative environment, but it can also place a trial at risk of becoming uninformative due to lack of rigor, quality control, or effective recruitment, resulting in premature discontinuation and/or non-publication. Key factors that support informativeness are having the right team and resources during study planning and implementation and adequate funding to support performance activities. This communication draws on the experience of the National Center for Advancing Translational Science (NCATS) Trial Innovation Network (TIN) to develop approaches for enhancing the informativeness of clinical trials. We distilled this information into three principles: (1) assemble a diverse team, (2) leverage existing processes and systems, and (3) carefully consider budgets and contracts. The TIN, comprised of NCATS, three Trial Innovation Centers, a Recruitment Innovation Center, and 60+ CTSA Program hubs, provides resources to investigators who are proposing multicenter collaborations. In addition to sharing principles that support the informativeness of clinical trials, we highlight TIN-developed resources relevant for multicenter trial initiation and conduct.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence
    Ziedonis, Douglas M.
    Amass, Leslie
    Steinberg, Marc
    Woody, George
    Krejci, Jonathan
    Annon, Jeffrey J.
    Cohen, Allan J.
    Waite-O'Brien, Nancy
    Stine, Susan M.
    McCarty, Dennis
    Reid, Malcolm S.
    Brown, Lawrence S., Jr.
    Maslansky, Robert
    Winhusen, Theresa
    Babcock, Dean
    Brigham, Greg
    Muirq, Joan
    Orr, Deborah
    Buchan, Betty J.
    Horton, Terry
    Ling, Walter
    DRUG AND ALCOHOL DEPENDENCE, 2009, 99 (1-3) : 28 - 36
  • [32] Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network
    Ferket, Bart S.
    Ailawadi, Gorav
    Gelijns, Annetine C.
    Acker, Michael A.
    Hohmann, Samuel F.
    Chang, Helena L.
    Bouchard, Denis
    Meltzer, David O.
    Michler, Robert E.
    Moquete, Ellen G.
    Voisine, Pierre
    Mullen, John C.
    Lala, Anuradha
    Mack, Michael J.
    Gillinov, A. Marc
    Thourani, Vinod H.
    Miller, Marissa A.
    Gammie, James S.
    Parides, Michael K.
    Bagiella, Emilia
    Smith, Robert L.
    Smith, Peter K.
    Hung, Judy W.
    Gupta, Lopa N.
    Rose, Eric A.
    O'Gara, Patrick T.
    Moskowitz, Alan J.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2018, 11 (11): : e004466
  • [33] Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials - A T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study
    Zhang, Qiang
    Werys, Konrad
    Popescu, Iulia A.
    Biasiolli, Luca
    Ntusi, Ntobeko A. B.
    Desai, Milind
    Zimmerman, Stefan L.
    Shah, Dipan J.
    Autry, Kyle
    Kim, Bette
    Kim, Han W.
    Jenista, Elizabeth R.
    Huber, Steffen
    White, James A.
    McCann, Gerry P.
    Mohiddin, Saidi A.
    Boubertakh, Redha
    Chiribiri, Amedeo
    Newby, David
    Prasad, Sanjay
    Radjenovic, Aleksandra
    Dawson, Dana
    Schulz-Menger, Jeanette
    Mahrholdt, Heiko
    Carbone, Iacopo
    Rimoldi, Ornella
    Colagrande, Stefano
    Calistri, Linda
    Michels, Michelle
    Hofman, Mark B. M.
    Anderson, Lisa
    Broberg, Craig
    Andrew, Flett
    Sanz, Javier
    Bucciarelli-Ducci, Chiara
    Chow, Kelvin
    Higgins, David
    Broadbent, David A.
    Semple, Scott
    Hafyane, Tarik
    Wormleighton, Joanne
    Salerno, Michael
    He, Taigang
    Plein, Sven
    Kwong, Raymond Y.
    Jerosch-Herold, Michael
    Kramer, Christopher M.
    Neubauer, Stefan
    Ferreira, Vanessa M.
    Piechnik, Stefan K.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 330 : 251 - 258
  • [34] A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial
    Bashir, Qaiser
    Nishihori, Taiga
    Pasquini, Marcelo C.
    Martens, Michael J.
    Wu, Juan
    Alsina, Melissa
    Anasetti, Claudio
    Brunstein, Claudio
    Dawson, Peter
    Efebera, Yvonne
    Gasparetto, Cristina
    Geller, Nancy
    Giralt, Sergio
    Hall, Aric C.
    Koreth, John
    McCarthy, Philip
    Scott, Emma
    Stadtmauer, Edward A.
    Vesole, David H.
    Hari, Parameswaran
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (06): : 358e1 - 358e7
  • [35] A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid, detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network
    Ling, W
    Amass, L
    Shoptaw, S
    Annon, JJ
    Hillhouse, M
    Babcock, D
    Brigham, G
    Harrer, J
    Reid, M
    Muir, J
    Buchan, B
    Orr, D
    Woody, G
    Krejci, J
    Ziedonis, D
    ADDICTION, 2005, 100 (08) : 1090 - 1100
  • [36] Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial
    Knight, Jennifer M.
    Syrjala, Karen L.
    Majhail, Navneet S.
    Martens, Michael
    Le-Rademacher, Jennifer
    Logan, Brent R.
    Lee, Stephanie J.
    Jacobsen, Paul B.
    Wood, William A.
    Jim, Heather S. L.
    Wingard, John R.
    Horowitz, Mary M.
    Abidi, Muneer H.
    Fei, Mingwei
    Rawls, Laura
    Rizzo, J. Douglas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (12) : 2256 - 2263
  • [37] Defining clinical trial quality from the perspective of resource-limited settings: A qualitative study based on interviews with investigators, sponsors, and monitors conducting clinical trials in sub-Saharan Africa
    De Pretto-Lazarova, Angela
    Fuchs, Claudia
    van Eeuwijk, Peter
    Burri, Christian
    PLOS NEGLECTED TROPICAL DISEASES, 2022, 16 (01):
  • [38] Family nursing with the assistance of network improves clinical outcome and life quality in patients underwent coronary artery bypass grafting A consolidated standards of reporting trials-compliant randomized controlled trial
    Jin, Liying
    Pan, Ruijin
    Huang, Lihua
    Zhang, Haixia
    Jiang, Mi
    Zhao, Hao
    MEDICINE, 2020, 99 (50) : E23488
  • [39] Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: Secondary analyses from a NIDA Clinical Trials Network study
    Chakrabarti, Amit
    Woody, George E.
    Griffin, Margaret L.
    Subramaniam, Geetha
    Weiss, Roger D.
    DRUG AND ALCOHOL DEPENDENCE, 2010, 107 (2-3) : 253 - 256
  • [40] Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network
    Alousi, Amin M.
    Weisdorf, Daniel J.
    Logan, Brent R.
    Bolanos-Meade, Javier
    Carter, Shelly
    DiFronzo, Nancy
    Pasquini, Marcelo
    Goldstein, Steven C.
    Ho, Vincent T.
    Hayes-Lattin, Brandon
    Wingard, John R.
    Horowitz, Mary M.
    Levine, John E.
    BLOOD, 2009, 114 (03) : 511 - 517